128 related articles for article (PubMed ID: 9039224)
1. Immunohistochemical evaluation of transglutaminase C in tumours of salivary glands.
Lee CH; Lee SK; Chi JG; Park SC; Chung SI; Saitoh M; Shrestha P; Mori M
Eur J Cancer B Oral Oncol; 1996 Nov; 32B(6):401-6. PubMed ID: 9039224
[TBL] [Abstract][Full Text] [Related]
2. Over-expression of glutathione S-transferases, DT-diaphorase and an apparently tumour-specific cytosolic class-3 aldehyde dehydrogenase by Warthin tumours and mucoepidermoid carcinomas of the human parotid gland.
Sreerama L; Sladek NE
Arch Oral Biol; 1996 Jun; 41(6):597-605. PubMed ID: 8937651
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of the distribution of endogenous biotin and biotin-binding enzymes in ductal structures of salivary gland tumours.
Lu CS; Kashima K; Daa T; Yokoyama S; Yanagisawa S; Nakayama I
J Oral Pathol Med; 2000 Oct; 29(9):445-51. PubMed ID: 11016687
[TBL] [Abstract][Full Text] [Related]
4. Kallikrein-related peptidase 10 expression in salivary gland tissues and tumours.
Darling MR; Hashem NN; Zhang I; Mohamed AB; Fung K; Kwan K; Mara TW; Daley TD; Diamandis EP
Int J Biol Markers; 2012 Dec; 27(4):e381-8. PubMed ID: 23250777
[TBL] [Abstract][Full Text] [Related]
5. Immunoreactive tenascin in tumours of salivary glands: evidence for enhanced expression in tumour stroma and production by tumour cells.
Shrestha P; Sumitomo S; Ogata K; Yamada K; Takai Y; Yang L; Mori M
Eur J Cancer B Oral Oncol; 1994 Nov; 30B(6):393-9. PubMed ID: 7536507
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of E-cadherin in certain types of salivary gland tumours.
Andreadis D; Epivatianos A; Mireas G; Nomikos A; Poulopoulos A; Yiotakis J; Barbatis C
J Laryngol Otol; 2006 Apr; 120(4):298-304. PubMed ID: 16623973
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical evaluation of the Ca(2+)-binding S-100 proteins S-100A1, S-100A2, S-100A4, S-100A6 and S-100B in salivary gland tumors.
Huang JW; Ming Z; Shrestha P; Mori M; Ilg E; Schäfer BW; Heizmann CW
J Oral Pathol Med; 1996 Nov; 25(10):547-55. PubMed ID: 8986967
[TBL] [Abstract][Full Text] [Related]
8. Amylase as an additional marker of salivary gland neoplasms. An immunoperoxidase study.
Caselitz J; Seifert G; Grenner G; Schmidtberger R
Pathol Res Pract; 1983 Mar; 176(2-4):276-83. PubMed ID: 6190154
[TBL] [Abstract][Full Text] [Related]
9. MUC1 and MUC2 expression in salivary gland tumors and in non-neoplastic salivary gland tissue.
Mannweiler S; Beham A; Langner C
APMIS; 2003 Oct; 111(10):978-84. PubMed ID: 14616551
[TBL] [Abstract][Full Text] [Related]
10. CK7+/CK20- immunoexpression profile is typical of salivary gland neoplasia.
Meer S; Altini M
Histopathology; 2007 Jul; 51(1):26-32. PubMed ID: 17593078
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical distribution of human epidermal growth factor in salivary gland tumours.
Mori M; Naito R; Tsukitani K; Okada Y; Hayashi T; Kato K
Virchows Arch A Pathol Anat Histopathol; 1987; 411(6):499-507. PubMed ID: 2823456
[TBL] [Abstract][Full Text] [Related]
12. Maspin expression in normal and neoplastic salivary gland.
Navarro Rde L; Martins MT; de Araújo VC
J Oral Pathol Med; 2004 Aug; 33(7):435-40. PubMed ID: 15250837
[TBL] [Abstract][Full Text] [Related]
13. Tenascin in salivary gland tumours.
Soini Y; Pääkkö P; Virtanen I; Lehto VP
Virchows Arch A Pathol Anat Histopathol; 1992; 421(3):217-22. PubMed ID: 1384222
[TBL] [Abstract][Full Text] [Related]
14. Hybrid tumours of salivary glands. Definition and classification of five rare cases.
Seifert G; Donath K
Eur J Cancer B Oral Oncol; 1996 Jul; 32B(4):251-9. PubMed ID: 8776422
[TBL] [Abstract][Full Text] [Related]
15. Comparison of integrin alpha chain expression in benign and malignant salivary gland tumors.
Franchi A; Santoro R; Paglierani M; Bondi R
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 May; 83(5):588-95. PubMed ID: 9159820
[TBL] [Abstract][Full Text] [Related]
16. Localization of salivary amylase and epithelial membrane antigen in salivary gland tumours by means of immunoperoxidase and immunogold-silver techniques.
Egan M; Crocker J; Nar P
J Laryngol Otol; 1988 Mar; 102(3):242-7. PubMed ID: 2451703
[TBL] [Abstract][Full Text] [Related]
17. STAT3 expression in salivary gland tumours.
de Araújo VC; Furuse C; Cury PR; Altemani A; de Araújo NS
Oral Oncol; 2008 May; 44(5):439-45. PubMed ID: 17826306
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase VI: a novel marker for salivary serous acinar differentiation and its application to discriminate acinic cell carcinoma from mammary analogue secretory carcinoma of the salivary gland.
Hsieh MS; Jeng YM; Jhuang YL; Chou YH; Lin CY
Histopathology; 2016 Apr; 68(5):641-7. PubMed ID: 26212680
[TBL] [Abstract][Full Text] [Related]
19. Low p53 protein expression in salivary gland tumours compared with lung carcinomas.
Soini Y; Kamel D; Nuorva K; Lane DP; Vähäkangas K; Pääkkö P
Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):415-20. PubMed ID: 1333678
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the tumour suppressor genes, FHIT and WT-1, and the tumour rejection genes, BAGE, GAGE-1/2, HAGE, MAGE-1, and MAGE-3, in benign and malignant neoplasms of the salivary glands.
Nagel H; Laskawi R; Eiffert H; Schlott T
Mol Pathol; 2003 Aug; 56(4):226-31. PubMed ID: 12890744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
